Enanta shares soar after it and development partner AbbVie report phase 3 results of their direct-acting antiviral combo drug for hepatitis-C.
http://ift.tt/1kmEX3T
http://ift.tt/1kmEX3T
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment